PeptideDB

FR-229934 799841-02-4

FR-229934 799841-02-4

CAS No.: 799841-02-4

FR-229934 is a PDE V inhibitor. FR-229934 may be used in studies of pulmonary hypertension and erectile dysfunction. For
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

FR-229934 is a PDE V inhibitor. FR-229934 may be used in studies of pulmonary hypertension and erectile dysfunction. For more details, check and find the patent WO2019130052A1.

Physicochemical Properties


Molecular Formula C21H23CL2N3O3S
Molecular Weight 468.4
Exact Mass 467.084
CAS # 799841-02-4
PubChem CID 11259905
Appearance White to yellow solid powder
LogP 6.605
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 4
Rotatable Bond Count 8
Heavy Atom Count 30
Complexity 688
Defined Atom Stereocenter Count 0
SMILES

ClC1=C(C=CC(=C1)CN1C(C)=NC2C=CC(C(NS(CCCCC)(=O)=O)=O)=CC1=2)Cl

InChi Key QLXVZAXTUBLQJW-UHFFFAOYSA-N
InChi Code

InChI=1S/C21H23Cl2N3O3S/c1-3-4-5-10-30(28,29)25-21(27)16-7-9-19-20(12-16)26(14(2)24-19)13-15-6-8-17(22)18(23)11-15/h6-9,11-12H,3-5,10,13H2,1-2H3,(H,25,27)
Chemical Name

3-[(3,4-dichlorophenyl)methyl]-2-methyl-N-pentylsulfonylbenzimidazole-5-carboxamide
Synonyms

FR 229934; FR229934; FR-229934
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity



Solubility Data


Solubility (In Vitro) DMSO : ~100 mg/mL (~213.49 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (5.34 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (5.34 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.1349 mL 10.6746 mL 21.3493 mL
5 mM 0.4270 mL 2.1349 mL 4.2699 mL
10 mM 0.2135 mL 1.0675 mL 2.1349 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.